<DOC>
	<DOCNO>NCT00203710</DOCNO>
	<brief_summary>The primary purpose study safety effectiveness Concentric Retriever Device ( CRD ) ischemic stroke patient undergo clot retrieval CRD within 8 hour stroke symptom onset . The CRD approve U.S. Food Drug Administration retrieve foreign body ( piece metal ) blood vessel body . The CRD small metal wire loop end ( like corkscrew ) remove clots artery thereby restore blood flow brain . Prior version CRD may soft pull clot , corkscrew soft would pull cork . The current version CRD soft may effective retrieve clot . Hypothesis : By restore blood flow brain , stroke symptom may get good stroke may prevent get bad .</brief_summary>
	<brief_title>Concentric Retriever Device ( CRD ) Acute Ischemic Stroke</brief_title>
	<detailed_description>The primary objective ass safety efficacy Concentric Retriever treatment thrombotic occlusion originate internal carotid , middle cerebral ( M1 M2 segment ) , basilar , posterior cerebral vertebral artery . A maximum 50 patient may enrol single site , University California , Los Angeles . Primary endpoint : Achievement recanalization ( TIMI/TICI grade II III flow ) immediately post procedure without occurrence major complication assess . Major complication define vessel perforation , intramural arterial dissection , symptomatic intra-cranial hemorrhage , significant embolization previously uninvolved arterial territory . Secondary endpoint : Assessment patient 's neurological condition functional state use NIHSS , Barthel Index , Modified Rankin 30 90 day post-procedure . A composite major adverse event 30 90 day post-procedure report . Major adverse event define death new stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 ( ) Patients present within 8 hour stroke onset candidate treatment tPA clinical sign consistent diagnosis ischemic stroke impairment language , motor function , sensation , cognition , and/or gaze , vision . 1 ( b ) . Patients acute ischemic stroke treat intravenous thrombolytic therapy vascular imaging ( TCD , CTA , MRA , angiography ) show persistent occlusion end infusion treatment . 2 . Patients &gt; 18 year age . 3 . NIHSSS &gt; 7 4 . Angiogram show thrombotic occlusion originate internal carotid , middle cerebral ( M1 M2 segment ) , basilar , posterior cerebral , vertebral artery . 5 . Patient/patient guardian willing comply protocol requirement return treatment center require clinical evaluation . 1 . Patient pregnant ( within child bear age ) . 2 . Patient baseline glucose &lt; 50mg/dL ( &lt; 50 mg/mM ) . 3 . Patient excessive arterial tortuosity precludes device reach target area . 4 . Patient know hemorrhagic diathesis , coagulation factor deficiency , oral anticoagulant therapy INR &gt; 2.0 . 5 . Patient receive Heparin within 48 hour PTT great 2 time lab normal . 6 . Patient baseline platelet &lt; 30,000 . 7 . Patient history severe allergy intraarterial contrast medium . 8 . Patient severe , sustained hypertension ( systolic blood pressure &gt; 185 mm Hg diastolic blood pressure &gt; 110 mm Hg ) . NOTE : If blood pressure successfully reduce maintain acceptable level use medication ( i.e . Nipride ) , patient enrol . 9 . CT Scan MRI reveals significant mass effect midline shift . 10 . Patient 's angiogram show arterial stenosis ( &gt; 50 % ) proximal embolus . 11 . Patient 's anticipated life expectancy le 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Concentric Retriever Device</keyword>
	<keyword>embolectomy</keyword>
	<keyword>acute ischemic stroke</keyword>
	<keyword>treatment</keyword>
</DOC>